← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 1.00 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 1.00 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.99 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Beta-frequency entrainment therapy targeting PV interneuron- (SST) — 0.98 LRP1-Dependent Tau Uptake Disruption (LRP1) — 0.98 Closed-loop tACS targeting EC-II parvalbumin interneurons to (PVALB) — 0.97 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.94 Dual-Receptor Antibody Shuttling (?) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 SASP-Driven Microglial Metabolic Reprogramming in Synaptic P (HK2/PFKFB3) — 0.93 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.93 Closed-loop transcranial alternating current stimulation to (SST) — 0.93 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Closed-loop tACS targeting entorhinal cortex layer II SST in (SST) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.92 TREM2-mediated microglial tau clearance enhancement (TREM2) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Alpha-gamma cross-frequency coupling enhancement to restore (SST) — 0.91 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91 sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy (?) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.90
Add
|
× Gamma Entrainment Synergy × Hypothesis 7: SST-SST1R/G
- · neurodegeneration · -
Composite 0.583
Price $0.57
Evidence For 5
Evidence Against 5
HBOT-induced improvements in neurovascular coupling create optimal metabolic milieu for gamma entrainment therapy targeting EC-II SST interneurons, enhancing their metabolic fitness for restoring gamma gating and blocking tau propagation.
SST, SSTR1, SSTR2 · neurodegeneration · -
Composite 0.971
Price $0.96
Evidence For 5
Evidence Against 2
Closed-loop gamma entrainment therapy enhances SST+ interneuron activity, which modulates astrocyte function through the SST-SST1R signaling axis. SST released from entorhinal cortex interneurons acts on astrocytes expressing SST1R/SST2R, enhancing their neuroprotective secretome production including MANF/GPNMB/HepaCAM, rescuing motor neuron RBP nuclear import.
Verdict Summary 0/10
dimensions won
Gamma Entrainment Synergy: HBOT-Enhanced
10/10
dimensions won
Hypothesis 7: SST-SST1R/Gamma Entrainmen
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Gamma Entrainment Synergy: HBO Hypothesis 7: SST-SST1R/Gamma Mechanistic 0.600 0.780 Evidence 0.520 0.650 Novelty 0.700 0.720 Feasibility 0.680 0.850 Impact 0.680 0.820 Druggability 0.700 0.880 Safety 0.720 0.750 Competition 0.550 0.700 Data 0.500 0.680 Reproducible 0.550 0.720
Evidence Gamma Entrainment Synergy: HBOT-Enhanced Cerebral Perfusion Supporting Evidence HBOT increases arteriolar luminal diameter and elevates CBF in 5xFAD mice PMID:34499614 SST+ interneurons in EC layer II provide critical gamma frequency gating PMID:N/A Combined HBOT + repetitive transcranial magnetic stimulation shows promise for vascular cognitive impairment PMID:37963686 GENUS (Cognito Therapeutics) 40Hz gamma light/sound in Phase 2 AD trials (NCT05655195) PMID:N/A Both HBOT and gamma entrainment have independent regulatory pathways; combination is immediately translatable PMID:N/A Contradicting Evidence Additive effect size ~40% lacks empirical basis and contradicts synergy claim PMID:N/A HBOT increases CBF in healthy mice; AD-associated neurovascular dysfunction (amyloid angiopathy, pericyte loss) may not PMID:N/A SST interneuron metabolic fitness concept is vague; other factors (homeostatic plasticity) may be more limiting PMID:N/A Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Supporting Evidence Gamma entrainment therapy restores hippocampal-cortical synchrony through SST interneuron modulation (established world PMID:WORLD_MODEL_071 Closed-loop focused ultrasound targeting EC-II SST interneurons blocks tau propagation (established world model, confide PMID:WORLD_MODEL_074 Astrocyte-neuron metabolic coupling is modulated by neuropeptide signaling including somatostatin PMID:31781038 Astrocyte diversity in ALS includes distinct phenotypes with common pathological processes affected by SST signaling PMID:32739211 Somatostatin receptor modulation affects neuroprotective factor secretion from astrocytes PMID:31781038 Contradicting Evidence SST-SST1R axis connection to MANF/GPNMB/HepaCAM secretion remains unproven; gamma entrainment studies primarily in Alzhe PMID:WORLD_MODEL_071 Mechanistic link between SST signaling and specific astrocyte protective factor secretion not experimentally validated PMID:32739211 Price History Overlay
Shared Evidence
No shared papers found across 0 total unique citations. These hypotheses draw from independent evidence bases.
Knowledge Graph Comparison
Gamma Entrainment Synergy: HBOT-Enhanced
0 edges
Top Node Types
Top Relations
Hypothesis 7: SST-SST1R/Gamma Entrainmen
2 edges
Top Relations promoted: Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome 1
promoted: Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse 1